Results · Apr-Jun 2026
Global Health Q1 FY27 results
Sales grew 27% to ₹1,304 crore from ₹1,031 crore in Apr-Jun 2025.
Operating profit grew 26% to ₹287 crore, an operating margin of 22.0% (unchanged from a year ago).
Net profit fell 1% to ₹157 crore from ₹159 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +13%, net profit +11%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 1,304 | 1,031 | +27% |
| Operating profit (EBITDA) | 286.8 | 227.0 | +26% |
| Operating margin | 22.0% | 22.0% | 0.0 pts |
| Net profit | 157.3 | 159.0 | −1% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.